Baillie Gifford US Growth (USA) Share Price, News & Analysis

Company Overview

The Trust aims to produce long-term capital growth by investing predominantly in equities of companies which are incorporated, domiciled or conducting a significant portion of their business in the United States of America. The maximum amount which may be invested directly in private companies shall not exceed 50% of the total assets of the Company, measured at the time of investment. We are bottom-up, growth investors with a long-term horizon. The portfolio consists of direct holdings in listed securities and private companies in up to a combined maximum of 90 companies or funds, typically with 30 or more listed security holdings. The team aims to deliver outstanding investment performance by harnessing the asymmetry of returns inherent in equity markets. We believe we will maximise our chances of achieving this aim by identifying the exceptional growth businesses in America and owning them for long enough that the advantages of their business models and cultural strengths become the dominant drivers of their valuations. We have observed that, increasingly, companies in the US are choosing to remain private for longer, and as such the public equity markets do not offer the full spectrum of growth investment opportunity that we have previously enjoyed. The Trust’s ability to invest up to 50% of NAV in private companies at the time of purchase gives us the flexibility to invest in what we believe are the exceptional growth companies in the US, whatever their listed status. We take a five-year view when investing in stocks and are not driven by short-term trends.

Key Stats

• Today's Range: 269.48 to 273
• 50-Day Range: 256.50 to 292.50
• 52-Week Range: 175.03 to 295
• Volume: 231,444 shs
• Average Volume: 4.28 million shs
• Market Capitalization: £828.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

USA Stock Analysis - Frequently Asked Questions

How have USA shares performed this year?

Baillie Gifford US Growth's stock was trading at GBX 281.50 on January 1st, 2025. Since then, USA shares have decreased by 3.6% and is now trading at GBX 271.50.
View the best growth stocks for 2025 here.

How were Baillie Gifford US Growth's earnings last quarter?

Baillie Gifford US Growth (LON:USA) released its earnings results on Tuesday, January, 21st. The company reported ($1.16) EPS for the quarter.

How do I buy shares of Baillie Gifford US Growth?

Shares of USA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Baillie Gifford US Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Baillie Gifford US Growth investors own include Bank of America (BAC), Coca-Cola (KO), CrowdStrike (CRWD), Glencore (GLEN), Kroger (KR), Lloyds Banking Group (LLOY) and Meta Platforms (META).

Company Calendar

• Last Earnings: 1/21/2025
• Today: 1/31/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Financial Services
• Current Symbol: LON:USA
• CUSIP: N/A
• CIK: N/A
• Web: www.bailliegifford.com
• Phone: 44 13 1275 2000
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 305,150,000
• Free Float: N/A
• Market Cap: £825.81 million
• Optionable: Not Optionable
• Beta: N/A